CONTENTS:
- Psychedelic microdosing: A subreddit analysis. Lea T., Amada N., Jungaberle H., p. 101-112.
- Psychedelic microdosing: Prevalence and subjective effects. Cameron L.P., Nazarian A., Olson D.E., p. 113-122.
- Current day auto-experimentation of psychotropic medications by French psychiatrists. Bernard J.C., Dessomme B., p. 123-129.
- Ayahuasca's antidepressant effects covary with behavioral activation as well as mindfulness. Mian M.N., Altman B.R., Earleywine M., p. 130-137.
- Characteristics of dispensary patients that limit alcohol after initiating cannabis. Hayat A., Piper B.J., p. 145-152.
- Explosive increase in tramadol use in Korea 2003-2013: Analysis of patient trends based on the Korea National Health Insurance database. Kim K., Lee H., Shin J.Y., p. 153-161.
- Substance dependence and hepatitis among tramadol prescription users: A study of former adolescent psychiatric inpatients in Northern Finland. Näkkäläjärvi I., Hakko H., Riala K., Riipinen P., p. 162-168.
- Preliminary evidence of pregabalin misuse among prescription and/or illicit opioid (mis)users. Buttram M.E., Kurtz S.P., p. 172-175.
- Mortality risk among heroin users accessing treatment: Natives and non-natives patients results of a longitudinal study. Pavarin R.M., Sanchini S., Marani S., Turino E., Tadonio L., Cantarelli B., p. 176-185.
- Racial/ethnic and gender differences in associations of medication-assisted therapy and reduced opioid use between outpatient treatment admission and discharge. Pro G., Utter J., Cram J., Baldwin J., p. 186-194.